Armistice Capital, LLC Tg Therapeutics, Inc. Transaction History

Armistice Capital, LLC

  • $7.69 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$8.9 - $21.84 $6.84 Million - $16.8 Million
-768,000 Closed
0 $0
Q1 2020

May 15, 2020
SELL
$7.14 - $15.99 $228,480 - $511,680
-32,000 Reduced 4.0%
768,000 $7.56 Million
Q4 2019

Feb 14, 2020
BUY
$5.1 - $11.2 $4.08 Million - $8.96 Million
800,000 New
800,000 $8.88 Million

Others Institutions Holding TGTX

# of Institutions
287
Shares Held
91.8M
Call Options Held
1.9M
Put Options Held
1.45M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.39B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email